Medicare Enrolled
Dr. Urmeel Patel, M.D.
Hematology & Oncology · Shenandoah, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Urmeel Patel is a hematology & oncology in Shenandoah, TX, with 13 years in practice. Based on federal Medicare data, Dr. Patel performed 127,457 Medicare services across 1,367 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $54,466 from 107 pharmaceutical and/or device companies across 1257 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice▲ Top 4% volume in TX$ $54,466 industry payments
Medicare Practice Summary
Medicare Utilization ↗127,457
Medicare services
Top 4% in TX for hematology & oncology
1,367
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,804 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 81,000 | $1 | $3 |
| Anti-nausea injection (fosaprepitant) | 11,850 | $0 | $1 |
| Contrast dye for imaging (iodine-based) | 10,400 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 10,380 | $18 | $54 |
| Dexamethasone injection (steroid) | 2,878 | $0 | $0 |
| MRI contrast dye injection (gadoterate) | 2,800 | $0 | $0 |
| Anti-nausea injection (ondansetron/Zofran) | 1,904 | $0 | $0 |
| Flow cytometry, additional marker | 1,579 | $19 | $62 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,101 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 733 | $23 | $82 |
| Office visit, established patient (30-39 min) | 728 | $92 | $346 |
| Administration of chemotherapy into vein, 1 hour or less | 341 | $100 | $374 |
| Drug injection, under skin or into muscle | 315 | $11 | $38 |
| Office visit, established patient (20-29 min) | 216 | $63 | $244 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 162 | $50 | $179 |
| Administration of additional new drug or substance into vein, 1 hour or less | 150 | $50 | $183 |
| Administration of chemotherapy into vein, each additional hour | 121 | $22 | $80 |
| Office visit, established patient, complex (40-54 min) | 76 | $131 | $480 |
| Flow cytometry technique for dna or cell analysis, first marker | 69 | $55 | $189 |
| Ct scan of chest before and after contrast | 68 | $58 | $519 |
| Ct scan of abdomen and pelvis before and after contrast | 63 | $193 | $906 |
| Hospital follow-up visit, high complexity | 56 | $89 | $287 |
| Irrigation of implanted venous access drug delivery device | 55 | $19 | $74 |
| Injection, diphenhydramine hcl, up to 50 mg | 51 | $1 | $3 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 50 | $1,149 | $5,253 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 50 | $109 | $295 |
| New patient office visit (45-59 min) | 45 | $123 | $445 |
| Infusion into a vein for hydration, each additional hour | 29 | $10 | $36 |
| Infusion, normal saline solution , 1000 cc | 27 | $2 | $7 |
| CT scan of chest, without contrast | 25 | $43 | $331 |
| Ct scan of chest with contrast | 24 | $64 | $416 |
| New patient office visit, complex (60-74 min) | 20 | $170 | $597 |
| Ct scan of abdomen and pelvis without contrast | 19 | $74 | $466 |
| CT scan of abdomen and pelvis with contrast | 16 | $165 | $807 |
| Initial hospital admission, high complexity | 16 | $134 | $501 |
| Nuclear medicine study of bone and/or joint whole body | 15 | $140 | $748 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $18 | $63 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 12 | $131 | $480 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
64.3% high complexity
33.3% medium
2.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$54,466
Total received (2018-2024)
Avg $7,781/year across 7 years
Top 11% in TX for hematology & oncology
107
Companies
1,257
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$25,977 (47.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,750 (45.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,740 (6.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$20,409
2023$18,871
2022$4,947
2021$3,617
2020$1,636
2019$3,990
2018$997
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$10,538
Bayer Healthcare Pharmaceuticals Inc.
$7,013
Regeneron Pharmaceuticals, Inc.
$3,112
Pharmacosmos Therapeutics Inc.
$3,097
Janssen Biotech, Inc.
$2,774
Genentech USA, Inc.
$2,747
Karyopharm Therapeutics Inc.
$2,566
Novartis Pharmaceuticals Corporation
$1,588
Amgen Inc.
$1,444
US Oncology Corporate, Inc.
$1,202
GENZYME CORPORATION
$978
Celgene Corporation
$959
Daiichi Sankyo Inc.
$926
GlaxoSmithKline, LLC.
$919
E.R. Squibb & Sons, L.L.C.
$915
Astellas Pharma US Inc
$850
PFIZER INC.
$829
Lilly USA, LLC
$657
ABBVIE INC.
$623
Seagen Inc.
$559
Takeda Pharmaceuticals U.S.A., Inc.
$480
Incyte Corporation
$450
Eisai Inc.
$437
Rigel Pharmaceuticals, Inc.
$378
Gilead Sciences, Inc.
$378
SOBI, INC
$362
Alexion Pharmaceuticals, Inc.
$346
Bayer HealthCare Pharmaceuticals Inc.
$323
Dendreon Pharmaceuticals LLC
$308
Merck Sharp & Dohme LLC
$298
Sirtex Medical Inc
$280
Regeneron Healthcare Solutions, Inc.
$271
EISAI INC.
$239
Stemline Therapeutics Inc.
$237
Ipsen Biopharmaceuticals, Inc
$225
Merck Sharp & Dohme Corporation
$217
Myriad Genetic Laboratories, Inc.
$208
AVEO Pharmaceuticals, Inc.
$205
Janssen Pharmaceuticals, Inc
$203
Foundation Medicine, Inc.
$201
BeiGene USA, Inc.
$181
Pharmacyclics LLC, An AbbVie Company
$180
PUMA BIOTECHNOLOGY, INC.
$168
Blueprint Medicines Corporation
$163
Emmaus Medical, Inc.
$163
Mirati Therapeutics, Inc.
$143
TerSera Therapeutics LLC
$142
Adaptive Biotechnologies Corporation
$129
JAZZ PHARMACEUTICALS INC.
$125
Deciphera Pharmaceuticals Inc.
$117
ARRAY BIOPHARMA INC
$116
TAIHO ONCOLOGY, INC.
$116
Dova Pharmaceuticals
$110
Boston Scientific Corporation
$109
Seattle Genetics, Inc.
$108
Puma Biotechnology, Inc.
$97
PharmaEssentia USA Corporation
$94
Verastem, Inc.
$94
Taiho Oncology, Inc.
$91
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
MorphoSys, US Inc.
$91
Kite Pharma, Inc.
$86
SpringWorks Therapeutics, Inc.
$65
Blue Earth Diagnostics Limited
$64
CTI BioPharma Corp.
$64
Nestle HealthCare Nutrition Inc.
$61
Exelixis Inc.
$59
G1 Therapeutics, Inc.
$57
AbbVie Inc.
$56
Aveo Pharmaceuticals, Inc.
$51
Myovant Sciences Inc.
$50
Spectrum Pharmaceuticals Inc.
$47
Kyowa Kirin, Inc.
$43
Tempus AI, Inc
$41
Teva Pharmaceuticals USA, Inc.
$38
Alnylam Pharmaceuticals Inc.
$36
Servier Pharmaceuticals LLC
$36
Fennec Pharmaceuticals, Inc.
$36
Sobi, Inc
$34
Acrotech Biopharma LLC
$34
Apellis Pharmaceuticals, Inc.
$33
Pharming Healthcare, Inc.
$32
AMAG Pharmaceuticals, Inc.
$32
Agios Pharmaceuticals, Inc.
$27
Secura Bio, Inc.
$26
Pharmacyclics LLC, an AbbVie Company
$25
TOLMAR Pharmaceuticals, Inc.
$25
Shield Therapeutics Inc
$24
Biocompatibles, Inc.
$24
Azurity Pharmaceuticals, Inc.
$24
Clovis Oncology, Inc.
$23
Jazz Pharmaceuticals Inc.
$22
EMD Serono, Inc.
$21
Aurobindo Pharma USA, Inc.
$21
Verity Pharmaceuticals Inc.
$21
TESARO, Inc.
$16
Sun Pharmaceutical Industries Inc.
$15
Lexicon Pharmaceuticals, Inc.
$14
Epizyme, Inc.,
$14
Tactile Systems Technology Inc
$14
Immunomedics, Inc.
$14
Coherus Biosciences Inc.
$14
RECORDATI_RARE_DISEASES_INC.
$13
EUSA Pharma (US) LLC
$13
ADC Therapeutics America, Inc.
$13
Heron Therapeutics, Inc.
$12
Genentech, Inc.
$6
Top 3 companies account for 37.9% of total payments
Associated products mentioned in payments ›
ABECMA · ACCRUFER · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Axumin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Empaveli · Endari · Enhertu · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · Flexitouch Plus · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LINZESS · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · Monoferric · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · OXLUMO · Onivyde · Orserdu · PADCEV · PIQRAY · POLIVY · POTELIGEO · PRECISETUMOR · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RUCONEST · RYBREVANT · Rezlidhia · Rituxan · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SYLVANT · SYNAGIS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · THERASPHERE - BIO · TIBSOVO · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tazverik · TheraSphere Y90 Glass Microspheres 10 GBq · Trelstar · Trodelvy · Truxima · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (48%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $43 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
27
Per 100K population
4.1
County median income
$97,266
Nearest hospital
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (consulting-driven, top 11%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Patel performed 81,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $54,466 from 107 companies across 1,257 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other hematology & oncologys in Shenandoah?
Dr. Patel's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Shenandoah
Browse hematology & oncologys in Shenandoah ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc..
By company
Regeneron Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Pharmaceuticals, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology